RxDoctor Payments Data

Joseph Schuld

Physician Assistant · Passaic, NJNPI 1144800624

Payments from drug & device makers

$707in general payments, 2019–2025

Across 28 payments — averaging $25.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$205
  • Inari Medical, Inc.$156
  • AstraZeneca$125
  • Novartis$36
  • Amgen$31
  • Bard Peripheral Vascular, Inc.$27
  • plus $127 from 7 others

What the payments were for

  • Food & beverage$707100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$707 in reported general payments places this provider in the 65th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey

Medicare billing

Part B allowed, 2024
$35,236
Medicare patients
236
Services billed
379

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban84$73,728
EntrestoSacubitril/Valsartan51$48,483
FarxigaDapagliflozin Propanediol25$31,898
XareltoRivaroxaban26$25,469
JardianceEmpagliflozin13$11,507
Metoprolol Succinate154$1,717
Cilostazol71$1,534
Atorvastatin Calcium101$1,076
Hydralazine Hcl30$990
Losartan Potassium69$809
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide64$789
Amlodipine Besylate126$761
ClopidogrelClopidogrel Bisulfate48$693
Carvedilol50$479
Lisinopril43$370

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$36$48,48351 claims
AstraZenecaFarxiga$125$31,89825 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in Passaic

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →